Ranibizumab With Prompt/Deferred Laser Or Alone Again Beats Laser

May 6, 2011

Ophthalmology: Two large studies were published which confirmed what was demonstrated last year- that injections of Ranibizumab (Lucentis) with deferred (> 24 weeks) or prompt laser was superior to laser alone for diabetic retinopathy involving the central macula. Only 2-3 more injecions were required after the first year. One of the studies suggested that even the injections alone without any laser was better. We really ought to re-consider laser as the standard of care, and most likely, Avastin is just as good.

 

 

You might also enjoy...

Comments

Jump down to form below to submit your own comments

Trackback URL
http://eyedocnews.com/005346-ranibizumab-with-promptdeferred-laser-or-alone-again-beats-laser/trackback/

Have insights to contribute? Please submit your comment below